Estimating the Impact of Switching from a Lower to Higher Valent Pneumococcal Conjugate Vaccine in Colombia, Finland, and The Netherlands: A Cost-Effectiveness Analysis

ConclusionIn Colombia, Finland, and The Netherlands, countries with diverse epidemiologic and population distributions, switching from a PCV10 to PCV13 program would significantly reduce the burden of IPD in all three countries in as few as 5 years.

http://link.springer.com/10.1007/s40121-020-00287-5

Source: Infectious Diseases and Therapy - February 23, 2020 Category: Infectious Diseases Source Type: research